No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Benzamides
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Male
-
Middle Aged
-
Piperazines / administration & dosage
-
Piperazines / adverse effects*
-
Psoriasis / chemically induced*
-
Psoriasis / pathology
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Skin / pathology
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate